Cerus Corp. (NASDAQ:CERS) shares reached a new 52-week high on Thursday . The company traded as high as $6.96 and last traded at $6.95, with a volume of 1,465,911 shares traded. The stock had previously closed at $6.70.

A number of research analysts have weighed in on the company. FBR & Co reiterated a “buy” rating on shares of Cerus Corp. in a report on Monday, July 11th. Cantor Fitzgerald reiterated a “buy” rating and set a $9.00 target price on shares of Cerus Corp. in a report on Thursday, July 7th. Robert W. Baird reiterated an “outperform” rating and set a $9.00 target price on shares of Cerus Corp. in a report on Wednesday, June 22nd. Finally, BTIG Research reiterated a “buy” rating and set a $10.00 target price on shares of Cerus Corp. in a report on Monday, June 20th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Cerus Corp. presently has an average rating of “Buy” and a consensus target price of $8.90.

The company has a 50 day moving average price of $6.26 and a 200 day moving average price of $5.83. The company’s market cap is $708.92 million.

Cerus Corp. (NASDAQ:CERS) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by $0.01. The business had revenue of $7.60 million for the quarter, compared to analyst estimates of $8.29 million. Cerus Corp.’s revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.17) earnings per share. Equities analysts predict that Cerus Corp. will post ($0.65) earnings per share for the current year.

Other hedge funds have recently made changes to their positions in the company. Rail Splitter Capital Management LLC increased its stake in shares of Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares during the last quarter. Stephens Inc. AR increased its stake in shares of Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares during the last quarter. Finally, California State Teachers Retirement System increased its stake in shares of Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock valued at $1,117,000 after buying an additional 3,126 shares during the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.